The Bob Harrington Show - Episode 20: Clopidogrel and proton-pump inhibitors with Deepak Bhatt

Summary: While there appears to be a biological rationale for the adverse interaction between proton-pump inhibitors (PPIs) and clopidogrel, observational studies—for what they are worth—have shown mixed results. The partial results from the COGENT randomized clinical trial—although it was halted early and gathered just four months of data—appear to show no adverse interaction. Dr Deepak Bhatt joins the show to discuss this complicated issue and offer practical guidance for the clinical practitioner. What are your thoughts? Join in by commenting below.